Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor

ACS Medicinal Chemistry Letters - United States
doi 10.1021/ml1000239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Discovery of Potent Anticancer Agent HJC0416, an Orally Bioavailable Small Molecule Inhibitor of Signal Transducer and Activator of Transcription 3 (STAT3)

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2014English

Synthesis and Pharmacological Characterization of Potent, Selective, and Orally Bioavailable Isoindoline Class Dipeptidyl Peptidase IV Inhibitors

Organic and Medicinal Chemistry Letters
2011English

MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology

English

Discovery and Preclinical Evaluation of BMS-955829 a Potent Positive Allosteric Modulator of mGluR5

English

Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2010English

Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists

English

Direct and Potent Regulation of Γ-Secretase by Its Lipid Microenvironment

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Discovery and Evaluation of N-Cyclopropyl-2, 4-Difluoro-5-((2-(Pyridin-2-Ylamino)thiazol-5-Ylmethyl)amino)benzamide (BMS-605541), a Selective and Orally Efficacious Inhibitor of Vascular Endothelial Growth Factor Receptor-2

English

Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lymphocyte-Specific Kinase: Synthesis, Structure-Activity Relationship, and in Vivo Anti-Inflammatory Activity

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy